Scientific article
The fate of sotorasib : a regulatory failure potentially harming patients
ContributorsRanganathan, Sruthi; Prasad, Vinay; Olivier, Timothée
Published inLancet oncology, vol. 25, no. 5, p. 549-552
Publication date2024-05
Keywords
- Humans
- Drug Approval / legislation & jurisprudence
- Antineoplastic Agents / adverse effects
- Antineoplastic Agents / therapeutic use
- United States Food and Drug Administration
- United States
Affiliation entities
Citation (ISO format)
RANGANATHAN, Sruthi, PRASAD, Vinay, OLIVIER, Timothée. The fate of sotorasib : a regulatory failure potentially harming patients. In: Lancet oncology, 2024, vol. 25, n° 5, p. 549–552. doi: 10.1016/S1470-2045(23)00616-2
Main files (1)
Article (Published version)
Identifiers
- PID : unige:183971
- DOI : 10.1016/S1470-2045(23)00616-2
- PMID : 38697153
Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S1470204523006162
Journal ISSN1470-2045
